Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 09-30.
Amounts in USD.
Revenue TTM
0
400M
800M
1.2B
Q4 '21: 470.6M
Q1 '22: 470.6M
Q2 '22: 479.7M
Q3 '22: 499.4M
Q4 '22: 532.6M
Q1 '23: 552.9M
Q2 '23: 596.5M
Q3 '23: 653.3M
Q4 '23: 699.3M
Q1 '24: 766.5M
Q2 '24: 850.1M
Q3 '24: 945.9M
Q4 '24: 1B
Q1 '25: 1.1B
Q2 '25: 1.1B
Q3 '25: 1.1B
Q4 '25: 1.1B
Q1 '26: 1.1B
Q2 '26: 1.1B
Q3 '26: 1.2B
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Gross Profit TTM
0
150M
300M
450M
Q4 '21: 75.1M
Q1 '22: 70.2M
Q2 '22: 72.2M
Q3 '22: 74M
Q4 '22: 85M
Q1 '23: 91M
Q2 '23: 105.4M
Q3 '23: 129M
Q4 '23: 147.6M
Q1 '24: 176.3M
Q2 '24: 205.6M
Q3 '24: 244.6M
Q4 '24: 273.1M
Q1 '25: 284.4M
Q2 '25: 305.1M
Q3 '25: 311.3M
Q4 '25: 324.4M
Q1 '26: 336.3M
Q2 '26: 340.8M
Q3 '26: 348.2M
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Operating Income TTM
-80M
0
80M
160M
240M
Q4 '21: 1M
Q1 '22: -3M
Q2 '22: -1.5M
Q3 '22: 727K
Q4 '22: 7.2M
Q1 '23: 12.6M
Q2 '23: 22.4M
Q3 '23: 43.1M
Q4 '23: 62.5M
Q1 '24: 87.3M
Q2 '24: 116.7M
Q3 '24: 152.5M
Q4 '24: 178.8M
Q1 '25: 188.5M
Q2 '25: 207.9M
Q3 '25: 210.7M
Q4 '25: 217.9M
Q1 '26: 225.1M
Q2 '26: 223.7M
Q3 '26: 227.7M
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Net Income TTM
-70M
0
70M
140M
210M
Q4 '21: 631K
Q1 '22: -1.9M
Q2 '22: -2.8M
Q3 '22: 8.3M
Q4 '22: 13.7M
Q1 '23: 17.7M
Q2 '23: 27.4M
Q3 '23: 36.8M
Q4 '23: 54.5M
Q1 '24: 77.4M
Q2 '24: 102.5M
Q3 '24: 130.2M
Q4 '24: 149.8M
Q1 '25: 160.5M
Q2 '25: 173.4M
Q3 '25: 175.4M
Q4 '25: 180.7M
Q1 '26: 187.4M
Q2 '26: 186.9M
Q3 '26: 190.9M
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Cost of Revenue TTM
0
300M
600M
900M
Q4 '21: 395.5M
Q1 '22: 400.3M
Q2 '22: 407.5M
Q3 '22: 425.3M
Q4 '22: 447.6M
Q1 '23: 461.8M
Q2 '23: 491.1M
Q3 '23: 524.3M
Q4 '23: 551.8M
Q1 '24: 590.2M
Q2 '24: 644.6M
Q3 '24: 701.3M
Q4 '24: 739.3M
Q1 '25: 775.4M
Q2 '25: 778.2M
Q3 '25: 770.1M
Q4 '25: 779.9M
Q1 '26: 777.8M
Q2 '26: 791.3M
Q3 '26: 809.3M
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
Operating Cash Flow TTM
-100M
0
100M
200M
300M
Q4 '20: 72.4M
Q1 '21: 45.1M
Q2 '21: 46.9M
Q3 '21: -20.7M
Q4 '21: -30.5M
Q1 '22: -33.1M
Q2 '22: -25.4M
Q3 '22: -18.6M
Q4 '22: -3.6M
Q1 '23: 23.7M
Q2 '23: 64.9M
Q3 '23: 129.5M
Q4 '23: 182.6M
Q1 '24: 267M
Q2 '24: 227.9M
Q3 '24: 191.9M
Q4 '25: 167.9M
Q1 '26: 174.5M
Q2 '26: 203.3M
Q3 '26: 256.1M
Q1 '21
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '25
Q3 '26
Free Cash Flow TTM
-90M
0
90M
180M
270M
Q4 '20: 67.2M
Q1 '21: 41.4M
Q2 '21: 43.6M
Q3 '21: -24.1M
Q4 '21: -33.4M
Q1 '22: -35.5M
Q2 '22: -27.8M
Q3 '22: -20.8M
Q4 '22: -6M
Q1 '23: 19M
Q2 '23: 60.2M
Q3 '23: 124.8M
Q4 '23: 174.7M
Q1 '24: 260.7M
Q2 '24: 221.3M
Q3 '24: 184.6M
Q4 '25: 154.8M
Q1 '26: 161.5M
Q2 '26: 192.5M
Q3 '26: 244M
Q1 '21
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '25
Q3 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
15M
30M
45M
Q2 '20: 11.7M
Q3 '20: 11.7M
Q1 '21: 11.7M
Q2 '21: 11.7M
Q3 '21: 11.7M
Q1 '22: 11.8M
Q2 '22: 11.8M
Q3 '22: 11.9M
Q1 '23: 12.1M
Q2 '23: 12.1M
Q3 '23: 12.1M
Q1 '24: 12.2M
Q2 '24: 12.2M
Q3 '24: 12.2M
Q1 '25: 12.2M
Q2 '25: 36.5M
Q3 '25: 36.5M
Q1 '26: 12.2M
Q2 '26: 36.6M
Q3 '26: 36.6M
Q3 '20
Q3 '21
Q3 '22
Q3 '23
Q3 '24
Q3 '25
Q3 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-5.00
0.00
5.00
10.00
15.00
Q4 '21: 0.06
Q1 '22: -0.15
Q2 '22: -0.23
Q3 '22: 0.70
Q4 '22: 1.15
Q1 '23: 1.49
Q2 '23: 2.29
Q3 '23: 3.05
Q4 '23: 4.49
Q1 '24: 6.37
Q2 '24: 8.42
Q3 '24: 10.69
Q4 '24: 12.29
Q1 '25: 13.17
Q2 '25: 11.69
Q3 '25: 9.22
Q4 '25: 9.67
Q1 '26: 10.21
Q2 '26: 10.19
Q3 '26: 10.29
Q1 '22
Q4 '22
Q3 '23
Q2 '24
Q1 '25
Q4 '25
Q3 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.